BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $100,078 | $67,666 | $65,268 | $62,238 |
| - Cash | $2,390 | $5,355 | $1,736 | $4,117 |
| + Debt | $14,090 | $22,340 | $10,558 | $2,659 |
| Enterprise Value | $111,778 | $84,651 | $74,090 | $60,780 |
| Revenue | $25,188 | $12,672 | $5,498 | $2,102 |
| % Growth | 98.8% | 130.5% | 161.6% | – |
| Gross Profit | $13,942 | $5,633 | $1,219 | $670 |
| % Margin | 55.4% | 44.5% | 22.2% | 31.9% |
| EBITDA | -$9,724 | -$9,762 | -$9,125 | -$8,636 |
| % Margin | -38.6% | -77% | -166% | -410.9% |
| Net Income | -$12,913 | -$12,564 | -$11,236 | -$9,827 |
| % Margin | -51.3% | -99.1% | -204.4% | -467.5% |
| EPS Diluted | -0.8 | -0.93 | -0.7 | -0.7 |
| % Growth | 14% | -32.9% | 0% | – |
| Operating Cash Flow | -$6,684 | -$8,522 | -$9,241 | -$6,794 |
| Capital Expenditures | -$2,835 | -$1,474 | -$1,256 | -$1,640 |
| Free Cash Flow | -$9,519 | -$9,996 | -$10,497 | -$8,434 |